{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:45:18Z","timestamp":1793036718538,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.contraception.2012.06.011","type":"journal-article","created":{"date-parts":[[2012,8,12]],"date-time":"2012-08-12T22:45:13Z","timestamp":1344811513000},"page":"26-37","source":"Crossref","is-referenced-by-count":176,"title":["First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review"],"prefix":"10.1016","volume":"87","author":[{"given":"Elizabeth G.","family":"Raymond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Winikoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.06.011_bb0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1363\/4304111","article-title":"Abortion incidence and access to services in the United States, 2008","volume":"43","author":"Jones","year":"2011","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2012.06.011_bb0010","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/AOG.0b013e3181b5ccf9","article-title":"Immediate complications after medical compared with surgical termination of pregnancy","volume":"114","author":"Niinimaki","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2307\/3097714","article-title":"Mifepristone for early medical abortion: experiences in France, Great Britain and Sweden","volume":"34","author":"Jones","year":"2002","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2012.06.011_bb0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.contraception.2009.03.008","article-title":"Unexpected heaping in reported gestational age for women undergoing medical abortion","volume":"80","author":"Sivin","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2011.07.013","article-title":"The combination of mifepristone and misoprostol for the termination of pregnancy","volume":"115","author":"Faundes","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2012.06.011_bb0030","series-title":"World Health Organization. Safe abortion: technical and policy guidance for health systems","year":"2012"},{"key":"10.1016\/j.contraception.2012.06.011_bb0035","series-title":"The care of women requesting induced abortion: evidence-based clinical guideline number 7","author":"Royal College of Obstetricians and Gynaecologists","year":"2011"},{"key":"10.1016\/j.contraception.2012.06.011_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00404-010-1590-2","article-title":"Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion","volume":"284","author":"Dahiya","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.contraception.2012.06.011_bb0045","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/01.AOG.0000124271.23499.84","article-title":"A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion","volume":"103","author":"Creinin","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0050","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/0140-6736(91)92102-8","article-title":"Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone","volume":"338","author":"Norman","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.06.011_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1742-4755-8-19","article-title":"Client preferences and acceptability for medical abortion and MVA as early pregnancy termination method in Northwest Ethiopia","volume":"8","author":"Woldetsadik","year":"2011","journal-title":"Reprod Health"},{"key":"10.1016\/j.contraception.2012.06.011_bb0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/13625180500284581","article-title":"Home use of two doses of misoprostol after mifepristone for medical abortion: a pilot study in Sweden and France","volume":"10","author":"Clark","year":"2005","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.06.011_bb0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1479-828X.2005.00380.x","article-title":"Early medical abortion: a new regimen up to 49 days' gestation","volume":"45","author":"Ashima","year":"2005","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0070","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1479-828X.2005.00484.x","article-title":"First trimester abortion with mifepristone and three doses of sublingual misoprostol: a pilot study","volume":"45","author":"Singh","year":"2005","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1028-4559(09)60251-5","article-title":"Use of mifepristone and sublingual misoprostol for early medical abortion","volume":"45","author":"Lin","year":"2006","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0080","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1783\/1471189054483915","article-title":"Home self-administration of misoprostol for medical abortion up to 56 days' gestation","volume":"31","author":"Hamoda","year":"2005","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.06.011_bb0085","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.contraception.2003.07.004","article-title":"A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation","volume":"68","author":"Hamoda","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0090","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.contraception.2007.08.012","article-title":"Termination of early pregnancy using flexible, low-dose mifepristone-misoprostol regimens","volume":"76","author":"Heikinheimo","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0095","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.contraception.2004.05.005","article-title":"Results and lessons learned from a small medical abortion clinical study in Turkey","volume":"70","author":"Akin","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/13625180902916020","article-title":"Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone","volume":"14","author":"Akin","year":"2009","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.06.011_bb0105","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1046\/j.1471-0528.2002.02156.x","article-title":"Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases","volume":"109","author":"Ashok","year":"2002","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0110","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/HUMREP\/10.6.1521","article-title":"Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion","volume":"10","author":"Baird","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.06.011_bb0115","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/humrep\/16.10.2098","article-title":"Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation","volume":"16","author":"Bartley","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.06.011_bb0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0010-7824(00)00154-2","volume":"62","author":"Bhattachary","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.contraception.2003.08.019","article-title":"The medical abortion experiences of married and unmarried women in Tunis, Tunisia","volume":"69","author":"Blum","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/13625187.2011.555568","article-title":"Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curacao","volume":"16","author":"Boersma","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.06.011_bb0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/13625180500361058","article-title":"Mifepristone medical abortion in Albania: results from a pilot clinical research study","volume":"11","author":"Bracken","year":"2006","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.06.011_bb0140","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijgo.2009.09.027","article-title":"Home administration of misoprostol for early medical abortion in India","volume":"108","author":"Bracken","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2012.06.011_bb0145","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1447-0756.2008.00864.x","article-title":"Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial","volume":"35","author":"Chawdhary","year":"2009","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.contraception.2012.06.011_bb0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3126\/kumj.v7i3.2725","article-title":"Early pregnancy termination with a simplified mifepristone: medical abortion outpatient regimen","volume":"7","author":"Chuni","year":"2009","journal-title":"Kathmandu Univ Med J"},{"key":"10.1016\/j.contraception.2012.06.011_bb0155","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/AOG.0b013e3181c996f3","article-title":"Alternatives to a routine follow-up visit for early medical abortion","volume":"115","author":"Clark","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0160","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1471-0528.2006.01208.x","article-title":"Are two doses of misoprostol after mifepristone for early abortion better than one?","volume":"114","author":"Coyaji","year":"2007","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0165","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1067\/mob.2003.131","article-title":"Mifepristone and misoprostol and methotrexate\/misoprostol in clinical practice for abortion","volume":"188","author":"Creinin","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0170","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/01.AOG.0000258298.35143.d2","article-title":"Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial","volume":"109","author":"Creinin","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0175","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4103\/0019-5359.16505","article-title":"Evaluation of the efficacy of mifepristone\/misoprostol and methotrexate\/misoprostol for medical abortion","volume":"59","author":"Dahiya","year":"2005","journal-title":"Indian J Med Sci"},{"key":"10.1016\/j.contraception.2012.06.011_bb0180","first-page":"141","article-title":"Bleeding patterns after early abortion with mifepristone and misoprostol or manual vacuum aspiration","volume":"55","author":"Davis","year":"2000","journal-title":"J Am Med Womens Assoc"},{"key":"10.1016\/j.contraception.2012.06.011_bb0185","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1471-0528.1994.tb11948.x","article-title":"Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure","volume":"101","author":"el-Refaey","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0190","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0140-6736(00)04563-3","article-title":"Can women in less-developed countries use a simplified medical abortion regimen?","volume":"357","author":"Elul","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.06.011_bb0195","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijgo.2009.11.008","article-title":"Sublingual misoprostol for first trimester termination of pregnancy","volume":"109","author":"Fekih","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2012.06.011_bb0200","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0010-7824(02)00358-X","article-title":"Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days' gestation","volume":"66","author":"Fox","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0205","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00404-011-1881-2","article-title":"Simultaneous administration of mifepristone and misoprostol for early termination of pregnancy: a randomized controlled trial","volume":"283","author":"Goel","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.contraception.2012.06.011_bb0210","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1471-0528.2006.01179.x","article-title":"Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol","volume":"114","author":"Guest","year":"2007","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0215","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.contraception.2004.06.012","article-title":"Expanding medical abortion in Tunisia: women's experiences from a multi-site expansion study","volume":"70","author":"Hajri","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0220","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1471-0528.2005.00638.x","article-title":"A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation","volume":"112","author":"Hamoda","year":"2005","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0225","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/humrep\/17.6.1477","article-title":"A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy","volume":"17","author":"Jain","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.06.011_bb0230","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijgo.2009.02.007","article-title":"Acceptability and feasibility of medical abortion in Nepal","volume":"106","author":"Karki","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2012.06.011_bb0235","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/humrep\/deq037","article-title":"Home self-administration of vaginal misoprostol for medical abortion at 50\u201363 days compared with gestation of below 50 days","volume":"25","author":"Kopp Kallner","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.06.011_bb0240","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1028-4559(09)60252-7","article-title":"Concurrent use of mifepristone and misoprostol for early medical abortion","volume":"45","author":"Li","year":"2006","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tjog.2010.09.002","article-title":"Simultaneous use of mifepristone and misoprostol for early pregnancy termination","volume":"50","author":"Li","year":"2011","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0250","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.contraception.2007.05.088","article-title":"Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot study","volume":"76","author":"Lohr","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0255","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/oxfordjournals.humrep.a138287","article-title":"The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol","volume":"8","author":"McKinley","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.06.011_bb0260","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2005.05.017","article-title":"Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period","volume":"72","author":"Middleton","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0265","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.contraception.2007.03.010","article-title":"Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center","volume":"76","author":"Mundle","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0270","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.contraception.2004.10.006","article-title":"A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation","volume":"71","author":"Murthy","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0275","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.contraception.2010.09.002","article-title":"Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone","volume":"83","author":"Ngoc","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0280","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1471-0528.2004.00209.x","article-title":"Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam","volume":"111","author":"Ngoc","year":"2004","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0285","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.contraception.2009.08.008","article-title":"Feasibility of telephone follow-up after medical abortion","volume":"81","author":"Perriera","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0290","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0010-7824(01)00296-7","article-title":"Mifepristone abortion in minors","volume":"64","author":"Phelps","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0295","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0010-7824(01)00228-1","article-title":"Mifepristone followed on the same day by vaginal misoprostol for early abortion","volume":"64","author":"Pymar","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0300","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.contraception.2010.05.013","article-title":"Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days' LMP: a randomized controlled trial","volume":"82","author":"Raghavan","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0305","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.contraception.2008.09.001","article-title":"Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol","volume":"79","author":"Raghavan","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0310","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0010-7824(94)90009-4","article-title":"Termination of early pregnancy by two regimens of mifepristone with misoprostol and mifepristone with PG05 \u2014 a multicentre randomized clinical trial in China","volume":"50","author":"Sang","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(98)00150-4","article-title":"Low-dose mifepristone 200 mg and vaginal misoprostol for abortion","volume":"59","author":"Schaff","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0320","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0010-7824(01)00200-1","article-title":"Mifepristone and misoprostol for early abortion when no gestational sac is present","volume":"63","author":"Schaff","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0325","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0010-7824(99)00119-5","article-title":"Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days","volume":"61","author":"Schaff","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0330","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1001\/jama.284.15.1948","article-title":"Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial","volume":"284","author":"Schaff","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2012.06.011_bb0335","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0010-7824(02)00366-9","article-title":"Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy","volume":"66","author":"Schaff","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0340","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0010-7824(01)00229-3","article-title":"Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion","volume":"64","author":"Schaff","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0345","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.contraception.2004.12.013","article-title":"A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 days","volume":"71","author":"Schreiber","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0350","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1471-0528.2006.00948.x","article-title":"Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial","volume":"113","author":"Shannon","year":"2006","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0355","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/01.AOG.0000152003.94320.59","article-title":"Multicenter trial of a simplified mifepristone medical abortion regimen","volume":"105","author":"Shannon","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0360","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3126\/jnhrc.v7i2.3021","article-title":"Mifepristone and oral misoprostol for early medical abortion","volume":"7","author":"Shrivastava","year":"2009","journal-title":"J Nepal Health Res Counc"},{"key":"10.1016\/j.contraception.2012.06.011_bb0365","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1006753827740","article-title":"Early abortion by mifepristone (RU 486) followed by vaginal gel (meteneprost) versus oral (misoprostol) prostaglandin","volume":"15","author":"Takkar","year":"1999","journal-title":"Adv Contracept"},{"key":"10.1016\/j.contraception.2012.06.011_bb0370","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/humrep\/deg475","article-title":"A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation","volume":"18","author":"Tang","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.06.011_bb0375","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(98)00005-5","article-title":"Pilot study on the use of a two-week course of oral misoprostol in patients after termination of pregnancy with mifepristone and misoprostol","volume":"57","author":"Tang","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.06.011_bb0380","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/humrep\/14.3.722","article-title":"A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol","volume":"14","author":"Tang","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.06.011_bb0385","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/humrep\/17.11.2865","article-title":"A prospective randomized study on the measured blood loss in medical termination of early pregnancy by three different misoprostol regimens after pretreatment with mifepristone","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.06.011_bb0390","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/humrep\/17.7.1738","article-title":"Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9 weeks gestation","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.06.011_bb0395","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/humrep\/17.1.99","article-title":"The effect of contraceptive pills on the measured blood loss in medical termination of pregnancy by mifepristone and misoprostol: a randomized placebo controlled trial","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.06.011_bb0400","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1471-0528.1992.tb13707.x","article-title":"Induction of abortion with mifepristone and misoprostol in early pregnancy","volume":"99","author":"Thong","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0405","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijgo.2010.01.012","article-title":"Feasibility, efficacy, safety, and acceptability of mifepristone-misoprostol for medical abortion in the Democratic People's Republic of Korea","volume":"109","author":"Tran","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2012.06.011_bb0410","first-page":"277","article-title":"Medical abortion with mifepristone and misoprostol: a clinical trial in Taiwanese women","volume":"101","author":"Tsai","year":"2002","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.contraception.2012.06.011_bb0415","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S1470-0328(03)02430-3","article-title":"WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy","volume":"110","author":"von Hertzen","year":"2003","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0420","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1471-0528.2010.02636.x","article-title":"Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial","volume":"117","author":"von Hertzen","year":"2010","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0425","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-0528.2008.02034.x","article-title":"Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial","volume":"116","author":"von Hertzen","year":"2009","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0430","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(10)62229-5","article-title":"Can midlevel health-care providers administer early medical abortion as safely and effectively as doctors? A randomised controlled equivalence trial in Nepal","volume":"377","author":"Warriner","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.06.011_bb0435","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/AOG.0b013e31818d8eb4","article-title":"Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial","volume":"112","author":"Winikoff","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0440","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1471-0528.2000.tb13273.x","article-title":"Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial","volume":"107","author":"World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation","year":"2000","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0445","first-page":"CD002855","article-title":"Medical methods for first trimester abortion","volume":"11","author":"Kulier","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2012.06.011_bb0450","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1586\/eog.11.37","article-title":"Review of the literature on patient satisfaction with early medical abortion using mifepristone and misoprostol","volume":"6","author":"Swica","year":"2011","journal-title":"Expert Rev Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.06.011_bb0455","unstructured":"Allison P. Missing Data. Thousand Oaks, CA: Sage Publications, Inc; 2001."}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412006439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412006439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T15:48:08Z","timestamp":1562082488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412006439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0010782412006439"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.06.011","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}